{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:42:20Z","timestamp":1787740940132,"version":"build-2784847793"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007366","name":"Italian Multiple Sclerosis Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejphar.2025.177415","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:46:55Z","timestamp":1740185215000},"page":"177415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The anti-CGRP mAb Fremanezumab reverts the anti-inflammatory effects of CGRP in vitro but does not alter disease evolution in a mouse model of progressive multiple sclerosis"],"prefix":"10.1016","volume":"995","author":[{"given":"Alessandra","family":"Pistolesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Molli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Cesaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Chiarugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Buonvicino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2025.177415_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jnr.490290104","article-title":"Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis","volume":"29","author":"Boudard","year":"1991","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2025.177415_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106387","article-title":"The mitochondriogenic but not the immunosuppressant effects of mTOR inhibitors prompt neuroprotection and delay disease evolution in a mouse model of progressive multiple sclerosis","volume":"191","author":"Buonvicino","year":"2024","journal-title":"Neurobiol. Dis."},{"issue":"14","key":"10.1016\/j.ejphar.2025.177415_bib3","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1111\/bph.15058","article-title":"Neuroprotection induced by dexpramipexole delays disease progression in a mouse model of progressive multiple sclerosis","volume":"177","author":"Buonvicino","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177415_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113065","article-title":"Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution","volume":"322","author":"Buonvicino","year":"2019","journal-title":"Exp. Neurol."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177415_bib5","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1097\/j.pain.0000000000001291","article-title":"Trigeminal ganglion transcriptome analysis in 2 rat models of medication-overuse headache reveals coherent and widespread induction of pronociceptive gene expression patterns","volume":"159","author":"Buonvicino","year":"2018","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.ejphar.2025.177415_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1474-4422(19)30137-1","article-title":"Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial","volume":"18","author":"Cadavid","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2025.177415_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbi.2015.06.019","article-title":"Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound","volume":"50","author":"Cavone","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177415_bib8","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/head.13695","article-title":"A popperian view on anti-CGRP biologics in migraine","volume":"59","author":"Chiarugi","year":"2019","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177415_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/0333102418821662","article-title":"CGRP ligand and receptor monoclonal antibodies for migraine prevention: evidence review and clinical implications","volume":"39","author":"Dodick","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ejphar.2025.177415_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2022.100097","article-title":"Comprehensive phenotyping of cutaneous afferents reveals early-onset alterations in nociceptor response properties, release of CGRP, and hindpaw edema following spinal cord injury","volume":"12","author":"Eller","year":"2022","journal-title":"Neurobiol Pain"},{"issue":"13","key":"10.1016\/j.ejphar.2025.177415_bib11","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1073\/pnas.0701252104","article-title":"Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models","volume":"104","author":"Fabis","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177415_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jlb.67.5.669","article-title":"Calcitonin-gene related peptide (CGRP) inhibits interleukin-7-induced pre-B cell colony formation","volume":"67","author":"Fernandez","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177415_bib13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/head.12526","article-title":"Persistent headache in patients with multiple sclerosis starting treatment with fingolimod","volume":"55","author":"Fragoso","year":"2015","journal-title":"Headache"},{"issue":"17","key":"10.1016\/j.ejphar.2025.177415_bib14","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1080\/14656566.2023.2262384","article-title":"Migraine in multiple sclerosis patients: potential links and treatment approach","volume":"24","author":"Gklinos","year":"2023","journal-title":"Expet Opin. Pharmacother."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177415_bib15","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/01.shk.0000183395.29014.7c","article-title":"Calcitonin gene-related peptide inhibits local acute inflammation and protects mice against lethal endotoxemia","volume":"24","author":"Gomes","year":"2005","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177415_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s10194-017-0750-1","article-title":"The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis","volume":"18","author":"Hou","year":"2017","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.ejphar.2025.177415_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0076-6879(89)68013-5","article-title":"Use of microdialysis in neuroendocrinology","volume":"168","author":"Kendrick","year":"1989","journal-title":"Methods Enzymol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177415_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3959(97)00108-5","article-title":"Peripheral CGRP release as a marker for neurogenic inflammation: a model system for the study of neuropeptide secretion in rat paw skin","volume":"73","author":"Kilo","year":"1997","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177415_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhep.2009.03.022","article-title":"The neuropeptide calcitonin gene-related peptide (CGRP) prevents inflammatory liver injury in mice","volume":"51","author":"Kroeger","year":"2009","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177415_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1129-2377-14-70","article-title":"Multiple sclerosis presenting initially with a worsening of migraine symptoms","volume":"14","author":"Lin","year":"2013","journal-title":"J. Headache Pain"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177415_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-2567.2000.00082.x","article-title":"Calcitonin gene-related peptide inhibits lipopolysaccharide-induced interleukin-12 release from mouse peritoneal macrophages, mediated by the cAMP pathway","volume":"101","author":"Liu","year":"2000","journal-title":"Immunology"},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2025.177415_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.regpep.2011.05.014","article-title":"Calcitonin gene-related peptide prevents blood-brain barrier injury and brain edema induced by focal cerebral ischemia reperfusion","volume":"171","author":"Liu","year":"2011","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2025.177415_bib23","article-title":"CGRP sensory neurons promote tissue healing via neutrophils and macrophages","author":"Lu","year":"2024","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177415_bib24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/14740338.2021.1907342","article-title":"Deprescribing in migraine","volume":"20","author":"Martelletti","year":"2021","journal-title":"Expet Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177415_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/1352458507085551","article-title":"Lifetime and actual prevalence of pain and headache in multiple sclerosis","volume":"14","author":"Martinelli Boneschi","year":"2008","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177415_bib26","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/glia.23980","article-title":"Activated microglia drive demyelination via CSF1R signaling","volume":"69","author":"Marzan","year":"2021","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177415_bib27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/(SICI)1097-4547(19961101)46:3<316::AID-JNR4>3.0.CO;2-N","article-title":"The psychotomimetic drugs D-amphetamine and phencyclidine release calcitonin gene-related peptide in the limbic forebrain of the rat","volume":"46","author":"Mathe","year":"1996","journal-title":"J. Neurosci. Res."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177415_bib28","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1167\/iovs.12-9935","article-title":"Suppression of murine experimental autoimmune optic neuritis by mature dendritic cells transfected with calcitonin gene-related Peptide gene","volume":"53","author":"Matsuda","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.ejphar.2025.177415_bib29","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.4049\/jimmunol.1100028","article-title":"Calcitonin gene-related peptide is an important regulator of cutaneous immunity: effect on dendritic cell and T cell functions","volume":"186","author":"Mikami","year":"2011","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177415_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.ejphar.2025.177415_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.123392","article-title":"Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodies","volume":"469","author":"Nociti","year":"2025","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177415_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-0404.2011.01532.x","article-title":"Frequency and severity of headache is worsened by Interferon-beta therapy in patients with multiple sclerosis","volume":"125","author":"Patti","year":"2012","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ejphar.2025.177415_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2016.06.017","article-title":"The contribution of neutrophils to CNS autoimmunity","volume":"189","author":"Pierson","year":"2018","journal-title":"Clin. Immunol."},{"issue":"7952","key":"10.1016\/j.ejphar.2025.177415_bib34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41586-023-05753-x","article-title":"Bacteria hijack a meningeal neuroimmune axis to facilitate brain invasion","volume":"615","author":"Pinho-Ribeiro","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177415_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00023210-200822040-00003","article-title":"Current management of pain associated with multiple sclerosis","volume":"22","author":"Pollmann","year":"2008","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.ejphar.2025.177415_bib36","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/jnnp-2020-324674","article-title":"Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects","volume":"92","author":"Ray","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.177415_bib37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2018.07.005","article-title":"Calcitonin gene-related peptide decreases IL-1beta, IL-6 as well as Ym1, Arg1, CD163 expression in a brain tissue context-dependent manner while ameliorating experimental autoimmune encephalomyelitis","volume":"323","author":"Rossetti","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2025.177415_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2014.03.008","article-title":"Involvement of calcitonin gene-related peptide and receptor component protein in experimental autoimmune encephalomyelitis","volume":"271","author":"Sardi","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"22","key":"10.1016\/j.ejphar.2025.177415_bib39","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa1709038","article-title":"Fremanezumab for the preventive treatment of chronic migraine","volume":"377","author":"Silberstein","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177415_bib40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00401-013-1082-0","article-title":"Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons","volume":"125","author":"Singh","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177415_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10072-007-0805-1","article-title":"Multiple sclerosis and headache co-morbidity. A case-control study","volume":"28","author":"Vacca","year":"2007","journal-title":"Neurol. Sci."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177415_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045951","article-title":"Neuropeptides control the dynamic behavior of airway mucosal dendritic cells","volume":"7","author":"Voedisch","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177415_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1184766","article-title":"Calcitonin gene-related peptide: a potential protective agent in cerebral ischemia-reperfusion injury","volume":"17","author":"Xiong","year":"2023","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177415_bib44","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awx113","article-title":"Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis","volume":"140","author":"Zrzavy","year":"2017","journal-title":"Brain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925001694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925001694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T23:48:32Z","timestamp":1743983312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925001694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":44,"alternative-id":["S0014299925001694"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177415","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anti-CGRP mAb Fremanezumab reverts the anti-inflammatory effects of CGRP in vitro but does not alter disease evolution in a mouse model of progressive multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177415"}}